+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Huntington`s Disease Therapeutics: Global Strategic Business Report

  • PDF Icon

    Report

  • 172 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1227787

Competition in the Global HD Therapeutics Market is Non-existent

Global Huntington`s Disease Therapeutics Market to Reach $20 Billion by 2030

The global market for Huntington`s Disease Therapeutics estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$20 Billion by 2030, growing at a CAGR of 31.9% over the analysis period 2022-2030.

The U.S. Market is Estimated at $593.2 Million, While China is Forecast to Grow at 40.6% CAGR

The Huntington`s Disease Therapeutics market in the U.S. is estimated at US$593.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 40.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 25.7% and 28.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 27.2% CAGR.

Select Competitors (Total 23 Featured) -

  • Alnylam Pharmaceuticals, Inc.
  • Evotec AG
  • GlaxoSmithKline PLC
  • Horizon Therapeutics plc
  • Ionis Pharmaceuticals, Inc.
  • Raptor Pharmaceutical Corporation
  • Sangamo Biosciences, Inc.
  • Suven Life Sciences Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wave Life Sciences Ltd.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Huntington's Disease Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Huntington`s Disease Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Huntington`s Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Huntington`s Disease Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 5: USA Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 6: USA Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
CANADA
  • Table 7: Canada Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 8: Canada Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
JAPAN
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 9: Japan Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 10: Japan Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
CHINA
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 11: China Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 12: China Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
EUROPE
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 13: Europe Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: Europe Historic Review for Huntington`s Disease Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 15: Europe 18-Year Perspective for Huntington`s Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
FRANCE
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 16: France Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 17: France Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
GERMANY
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 18: Germany Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 19: Germany Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
ITALY
  • Table 20: Italy Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: Italy Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
UNITED KINGDOM
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 22: UK Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 23: UK Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
SPAIN
  • Table 24: Spain Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: Spain Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
RUSSIA
  • Table 26: Russia Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Russia Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
REST OF EUROPE
  • Table 28: Rest of Europe Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: Rest of Europe Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
ASIA-PACIFIC
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 30: Asia-Pacific Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 31: Asia-Pacific Historic Review for Huntington`s Disease Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 32: Asia-Pacific 18-Year Perspective for Huntington`s Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
AUSTRALIA
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • Table 33: Australia Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 34: Australia Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
INDIA
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • Table 35: India Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: India Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
SOUTH KOREA
  • Table 37: South Korea Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 38: South Korea Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
REST OF ASIA-PACIFIC
  • Table 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 40: Rest of Asia-Pacific Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
LATIN AMERICA
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • Table 41: Latin America Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 42: Latin America Historic Review for Huntington`s Disease Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 43: Latin America 18-Year Perspective for Huntington`s Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
ARGENTINA
  • Table 44: Argentina Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Argentina Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
BRAZIL
  • Table 46: Brazil Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: Brazil Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
MEXICO
  • Table 48: Mexico Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: Mexico Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
REST OF LATIN AMERICA
  • Table 50: Rest of Latin America Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Rest of Latin America Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
MIDDLE EAST
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • Table 52: Middle East Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 53: Middle East Historic Review for Huntington`s Disease Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 54: Middle East 18-Year Perspective for Huntington`s Disease Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
IRAN
  • Table 55: Iran Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 56: Iran Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
ISRAEL
  • Table 57: Israel Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 58: Israel Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
SAUDI ARABIA
  • Table 59: Saudi Arabia Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: Saudi Arabia Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
UNITED ARAB EMIRATES
  • Table 61: UAE Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 62: UAE Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
REST OF MIDDLE EAST
  • Table 63: Rest of Middle East Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 64: Rest of Middle East Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
AFRICA
  • Huntington`s Disease Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
  • Table 65: Africa Recent Past, Current & Future Analysis for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Africa Historic Review for Huntington`s Disease Therapeutics by Segment - Huntington`s Disease Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alnylam Pharmaceuticals, Inc.
  • Evotec AG
  • GlaxoSmithKline PLC
  • Horizon Therapeutics plc
  • Ionis Pharmaceuticals, Inc.
  • Raptor Pharmaceutical Corporation
  • Sangamo Biosciences, Inc.
  • Suven Life Sciences Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vertex Pharmaceuticals Inc.
  • Wave Life Sciences Ltd.

Table Information